MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The Future of Drug Delivery

Author(s)
Gao, Jingjing; Karp, Jeffrey M; Langer, Robert; Joshi, Nitin
Thumbnail
DownloadAccepted version (761.6Kb)
Terms of use
Creative Commons Attribution-Noncommercial-ShareAlike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
Drug delivery technologies have been proven to improve treatment outcomes in many ways, including enhancing therapeutic efficacy, reducing toxicity, increasing patient compliance, and enabling entirely new medical treatments. As the therapeutic landscape has evolved from small-molecule drugs to a new generation of therapeutics including proteins, peptides, monoclonal antibodies, nucleic acids, and even live cells, drug delivery technologies have also evolved to meet their unique delivery needs.
Date issued
2023-01-24
URI
https://hdl.handle.net/1721.1/163189
Department
Harvard-MIT Program in Health Sciences and Technology; Broad Institute of MIT and Harvard; Harvard-MIT Program in Health Sciences and Technology; Massachusetts Institute of Technology. Department of Chemical Engineering; Institute for Medical Engineering and Science
Journal
Chemistry of Materials
Publisher
American Chemical Society
Citation
Jingjing Gao, Jeffrey M Karp, Robert Langer, and Nitin Joshi. Chemistry of Materials 2023 35 (2), 359-363.
Version: Author's final manuscript

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.